Archive for the ‘misconduct investigations’ Category
Neurology has partially retracted a 2016 paper, replacing a figure and removing the author who contributed it after he was found guilty of misconduct.
The journal has replaced the figure with a new one that confirmed the findings of the original, and swapped the name of Andrew Cullinane with the scientist who constructed the new figure using a new dataset. Last year, the U.S. Office of Research Integrity declared that Cullinane had falsified data in this paper and one other while working as a postdoctoral fellow in the Medical Genetics Branch at the National Human Genome Research Institute (NHGRI).
Cullinane appears to be at Howard University in Washington D.C., according to his LinkedIn page. He is listed as an assistant professor in the Basic Sciences/Anatomy department of the university’s College of Medicine.
Here’s the partial retraction notice from the journal:
A cancer biologist based at the University of Maryland is transitioning out of research, as a journal has retracted three more of his papers.
Anil Jaiswal has now lost 13 papers, including, as we reported on February 6, six retractions issued earlier this month.
The Baltimore Sun reported this week that Jaiswal would no longer be conducting research at the University of Maryland School of Medicine, which we confirmed from a spokesperson:
The notices keep coming for diabetes researcher Mario Saad.
Diabetes has just retracted two more of his papers, both of which had been flagged by expressions of concern, citing problems with duplications. What’s more, the journal added another expression of concern to a 2009 paper on which Saad — based at the University of Campinas in São Paulo, Brazil — is listed as last author, again over concerns of duplication.
This isn’t Saad’s first run-in with the journal: In 2015, the researcher sued the publisher, the American Diabetes Association, after it issued expressions of concern for four of his papers. Later that year, a judge dismissed Saad’s defamation suit. The journal eventually retracted the papers.
The latest articles flagged by Diabetes appear to be part of an intricate publishing web, as the journal suggests all papers have used features of previous papers, and also include elements that have been republished by subsequent articles.
A journal has retracted a 2012 paper after the last author was unable to provide material to support the results presented in multiple figures.
The lack of supporting data came out during “an internal inquiry and subsequent legal proceedings,” according to the notice, issued by Cell Cycle.
The last author on the paper is Susana Gonzalez, who was dismissed from her position at the National Center for Cardiovascular Research (CNIC) in Spain last year.
Here’s the full notice:
Study about words’ effect on mood to be retracted after investigation finds evidence of data manipulation
A study examining whether the verb tense you use to describe a positive or negative experience influences your current mood will be retracted after a university investigation found the data had been manipulated.
By whom is the question — the notice cites an unnamed graduate student as the source of the manipulation, and says the only author, William Hart, was unaware of what had occurred.
We spoke with Hart, based at the University of Alabama, who declined to identify the student, nor say whether he or she was still working at the university. He did say the experience has been trying:
A journal has retracted six papers by a cancer researcher at the University of Maryland in Baltimore, bringing his total to 10.
The retractions cite an investigation by the university, and detail problems ranging from duplicated images, to tweaking an image to conceal particular bands, to including unreliable data.
Three of the papers had already been flagged by the journal with expressions of concern. The last author on all the papers is Anil Jaiswal, a professor in the pharmacology department. He has issued four previous retractions.
Bruce Jarrell, the Chief Academic and Research Officer and Senior Vice President at the University of Maryland, told us at least two more retractions are forthcoming:
It’s been a long and winding road for a whistleblower at Indiana University, South Bend.
After Mark Fox, a professor of management and entrepreneurship accused two business professors of plagiarism in 2012, a university investigation found one of the two men — Douglas Agbetsiafa, the former chair of the economics department — guilty of plagiarism, and terminated him in January 2014. The other professor was cleared of any wrongdoing — then sued Fox for defamation in June, 2014.
Fox won the case, but it dragged on. More than two years later, in December 2016, the Indiana Supreme Court declined to hear an appeal.
Fox told us:
According to Jeanine D’Armiento, the study’s last author, the newly retracted paper in Clinical Science contained a figure from a Journal of Hypertension paper published by the same authors earlier that year.
Last March, a PhD student at Harvard filed a misconduct allegation against his mentor, a prominent stem cell researcher. Three months later, he was taken from his home by police in the middle of the night for a forced psychiatric evaluation.
How did this happen? Read the rest of this entry »
Last year, Pfizer fired one of its scientists following an investigation that ended with requests for retraction of five of her studies. Now, two of the five papers, which were first flagged on PubPeer, have been retracted.
One notice cites the Pfizer investigation, which found that cancer researcher Min-Jean Yin had included duplicated images in all five papers. Yin is the last author on both retracted papers.
Here’s the first notice from Clinical Cancer Research, which says most or all of the questioned images appear to be duplicates, and Pfizer — who sponsored the study and requested the retraction — can’t find the originals:
Read the rest of this entry »